Clinical Trials Logo
  1. Home
  2. Mild Alzheimer's Disease
  3. NCT01013610

An Escalating Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LNK 754 in Elderly Volunteers and in Subjects With Mild Alzheimer's Disease

Mild Alzheimer's Disease Clinical Trial

Official title:
A Double-Blind, Randomized, Placebo-Controlled, Multiple, Escalating Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LNK 754 in Elderly Volunteers and in Subjects With Mild Alzheimer's Disease

Clinical Trial Summary

To evaluate the safety, tolerability, multiple dose plasma pharmacokinetics (PK) of LNK-754 in male and female elderly volunteers after dosing with LNK-754 for 7 days and in subjects with mild Alzheimer's Disease after dosing with LNK-754 for 28 days.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator)

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01013610
Study type Interventional
Source Link Medicine Corporation
Contact
Status Completed
Phase Phase 1
Start date November 2009
Completion date March 2011
View Details
See also
  Status Clinical Trial Phase
Completed NCT00243451 - Early Detection of Mild Cognitive Impairment in Individual Patients N/A
Recruiting NCT05872243 - pBFS Guided rTMS Treating Mild Alzheimer's Disease(AD) N/A
Recruiting NCT05417555 - Low Intensity Focused Ultrasound for Mild Cognitive Impairment and Mild Alzheimer's Disease N/A
Terminated NCT01482013 - Safety Study of HPP854 in Subjects With Mild Cognitive Impairment or a Diagnosis of Mild Alzheimer's Disease Phase 1
Completed NCT03186989 - Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IONIS-MAPTRx in Patients With Mild Alzheimer's Disease Phase 1/Phase 2
Not yet recruiting NCT03752294 - A Novel Therapeutic Target for Alzheimer's Disease in Men and Women 50-85 Years of Age. Phase 1
Recruiting NCT06058234 - Medicare Anti-Aβ mAb Coverage With Evidence Development (CED) Study
Active, not recruiting NCT03234686 - Deferiprone to Delay Dementia (The 3D Study) Phase 2
Completed NCT05233774 - Lomecel-B Effects on Alzheimer's Disease Phase 2
Terminated NCT00582855 - Effect of AQW051 in Patients With Memory Impairment Phase 2
Completed NCT01061489 - Sensory-cognitive and Physical Fitness Training in Mild Cognitive Impairment N/A
Completed NCT01548287 - A Study of the Safety and Tolerability of AZD5213 Effect on Sleep for Patients With Alzheimer's/Cognitive Impairment Phase 2
Terminated NCT00706186 - Safety and Feasibility of Sodium Oxybate in Mild Alzheimer's Disease Patients Phase 4